• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment

News
Article

The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.

The Food and Drug Administration (FDA) has granted 510(k) clearance to the artificial intelligence (AI)-powered CINA-ASPECTS, which may enhance the evaluation of stroke severity, and the AI-enabled CINA-IPE, which is geared toward bolstering the detection of incidental pulmonary embolism (PE).

Based off brain non-contrast computed tomography (NCCT) images, the CINA-ASPECTS modality provides heat mapping probabilities of sulcal effacement and hypodensity, identifies infarcted regions and offers automated ASPECT scoring for stroke severity, according to Avicenna.AI, the developer of CINA-ASPECTS.

FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment

The newly FDA-cleared CINA-ASPECTS reportedly provides automated ASPECTS scoring of stroke severity based off of non-contrast CT scans of the brain, according to Avicenna.AI. (Photo courtesty of Avicenna.AI.)

"The validations and multi-reader-multi-case studies we conducted highlighted that CINA-ASPECTS not only obtained outstanding standalone performance, but also demonstrated that its adjunctive use significantly improved clinicians' accuracy in the assessment of ASPECTS regions, compared to the conventional use of NCCT images alone," added Yasmina Chaibi, a clinical affairs manager for Avicenna.AI.

Avicenna.AI said the CINA-iPE modality, reportedly validated on 381 CT scans from 39 different CT scanner models, may facilitate timely triage with its strong sensitivity and specificity for the diagnosis of incidental PE.

Recent Videos
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Related Content
© 2024 MJH Life Sciences

All rights reserved.